🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- N44821101
- Market Cap
- Small Cap
- IPO
- 11/7/2017 · $15.00/share
Business: InflaRx N.V. is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Company Contact
- CEO
- Niels C. Riedemann
- CFO
- Thomas Taapken
- Investor Relations
- info@inflarx.de